kabutan

TOWA PHARMA, Last Fiscal Year Ordinary Profit Revised Upward to an Unexpected 7% Increase, Raises Record High Profit

Wed May 7, 2025 3:30 pm JST Revision

4553 TOWA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Guidance Update Report

TOWA PHARMACEUTICAL CO.,LTD. <4553> [TSE Prime] announced a performance revision after the market closed on May 7th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 has been revised upward 15.0%, from the previous forecast of 22.7 billion yen to 26.1 billion yen (compared to 24.4 billion yen in the previous period), record profits reach two consecutive terms, turning to a 6.6% increase in the consolidated ordinary profit outlook.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit is expected to increase 27.5%, from the previous forecast of 12.3 billion yen to 15.7 billion yen (compared to 14.2 billion yen in the same period of the previous year), turning to a 10.7% increase in the consolidated ordinary profit outlook.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 138,696 12,787 12,362 8,445 171.6 40 Feb 13, 2025 J-GAAP
Oct - Mar, 2024 New 136,096 12,687 15,762 12,345 250.8 40 May 7, 2025 J-GAAP
Revision Rate -1.9% -0.8% +27.5% +46.2% +46.2%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 262,100 23,300 22,700 15,000 304.7 70 Feb 13, 2025 J-GAAP
Mar, 2025 New 259,500 23,200 26,100 18,900 384.0 70 May 7, 2025 J-GAAP
Revision Rate -1.0% -0.4% +15.0% +26.0% +26.0%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 120,538 10,644 14,244 9,220 187.3 30 May 14, 2024 J-GAAP
Oct - Mar, 2024 Guidance 136,096 12,687 15,762 12,345 250.8 40 May 7, 2025 J-GAAP
YoY +12.9% +19.2% +10.7% +33.9% +33.9%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 208,859 5,514 5,141 2,201 44.7 60 May 15, 2023 J-GAAP
Mar, 2024 227,934 17,647 24,477 16,173 328.6 60 May 14, 2024 J-GAAP
Mar, 2025 Guidance 259,500 23,200 26,100 18,900 384.0 70 May 7, 2025 J-GAAP
YoY +13.8% +31.5% +6.6% +16.9% +16.8%

Related Articles